Breaking News, Collaborations & Alliances

Cellares Raises $255M to Launch First IDMO for Cell Therapies

Aims to launch the world's first commercial-scale IDMO smart factory.

Cellares, an integrated development and manufacturing organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing, has secured $255 million in Series C funding led by new investor Koch Disruptive Technologies. In a statement, Cellares explained that the new funding will be used to launch the world’s first commercial-scale IDMO smart factory, which seamlessly integrates advanced robotics, purpose-built technology, and interconnected software. The 118,000 ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters